|
1
|
Ferlay J, Shin HR, Bray F, et al:
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int
J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Gasparini G, Longo R, Torino F and
Morabito A: Therapy of breast cancer with molecular targeting
agents. Ann Oncol. 16:iv28–iv36. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su ZZ, Kang DC, Chen Y, et al:
Identification and cloning of human astrocyte genes displaying
elevated expression after infection with HIV-1 or exposure to HIV-1
envelope glycoprotein by rapid subtraction hybridization. RaSH
Oncogene. 21:3592–3602. 2002. View Article : Google Scholar
|
|
5
|
Yoo BK, Emdad L, Su ZZ, et al: Astrocyte
elevated gene-1 regulates hepatocellular carcinoma development and
progression. J Clin Invest. 119:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen D, Yoo BK, Santhekadur PK, et al:
Insulin-like growth factor-binding protein-7 functions as a
potential tumor suppressor in hepatocellular carcinoma. Clin Cancer
Res. 17:6693–6701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu H, Song X, Liu C, Xie L, Wei L and Sun
R: Knockdown of astrocyte elevated gene-1 inhibits proliferation
and enhancing chemo-sensitivity to cisplatin or doxorubicin in
neuroblastoma cells. J Exp Clin Cancer Res. 28:192009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Zhang N, Song LB, et al: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen W, Ke Z, Shi H, Yang S and Wang L:
Overexpression of AEG-1 in renal cell carcinoma and its correlation
with tumor nuclear grade and progression. Neoplasma. 57:522–529.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yaari S, Jacob-Hirsch J, Amariglio N,
Haklai R, Rechavi G and Kloog Y: Disruption of cooperation between
Ras and MycN in human neuroblastoma cells promotes growth arrest.
Clin Cancer Res. 11:4321–4330. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kikuno N, Shiina H, Urakami S, et al:
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thirkettle HJ, Girling J, Warren AY, et
al: LYRIC/AEG-1 is targeted to different subcellular compartments
by ubiquiti-nylation and intrinsic nuclear localization signals.
Clin Cancer Res. 15:3003–3013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ash SC, Yang DQ and Britt DE: LYRIC/AEG-1
overexpression modulates BCCIPalpha protein levels in prostate
tumor cells. Biochem Biophys Res Commun. 371:333–338. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu G, Chong RA, Yang Q, et al: MTDH
activation by 8q22 genomic gain promotes chemoresistance and
metastasis of poor-prognosis breast cancer. Cancer Cell. 15:9–20.
2009. View Article : Google Scholar :
|
|
15
|
Yoo BK, Gredler R, Vozhilla N, et al:
Identification of genes conferring resistance to 5-fluorouracil.
Proc Natl Acad Sci USA. 106:12938–12943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Desoize B and Madoulet C: Particular
aspects of platinum compounds used at present in cancer treatment.
Crit Rev Oncol Hematol. 42:317–325. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sciuto R, Festa A, Rea S, et al: Effects
of low-dose cisplatin on 89Sr therapy for painful bone metastases
from prostate cancer: A randomized clinical trial. J Nucl Med.
43:79–86. 2002.PubMed/NCBI
|
|
18
|
Dhar S, Kolishetti N, Lippard SJ and
Farokhzad OC: Targeted delivery of a cisplatin prodrug for safer
and more effective prostate cancer therapy in vivo. Proc Natl Acad
Sci USA. 108:1850–1855. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Liu L, Wu J, Ying Z, et al: Astrocyte
elevated gene-1 upregulates matrix metalloproteinase-9 and induces
human glioma invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SG, Jeon HY, Su ZZ, et al: Astrocyte
elevated gene-1 contributes to the pathogenesis of neuroblastoma.
Oncogene. 28:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song L, Li W, Zhang H, et al:
Over-expression of AEG-1 significantly associates with tumour
aggressiveness and poor prognosis in human non-small cell lung
cancer. J Pathol. 219:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Emdad L, Sarkar D, Su ZZ, et al:
Activation of the nuclear factor kappaB pathway by astrocyte
elevated gene-1: implications for tumor progression and metastasis.
Cancer Res. 66:1509–1516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harris T, Jimenez L, Kawachi N, et al:
Low-level expression of miR-375 correlates with poor outcome and
metastasis while altering the invasive properties of head and neck
squamous cell carcinomas. Am J Pathol. 180:917–928. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoo BK, Chen D, Su ZZ, et al: Molecular
mechanism of chemoresistance by astrocyte elevated gene-1. Cancer
Res. 70:3249–3258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fresno VJ, Casado E, de Castro J, Cejas P,
Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway
and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar
|
|
28
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee SG, Su ZZ, Emdad L, Sarkar D, Franke
TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival
pathways through PI3K-Akt signaling. Oncogene. 27:1114–1121. 2008.
View Article : Google Scholar
|
